Effect of BBT-877, a novel inhibitor of ATX, on a mouse model of type 1 diabetic nephropathy
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of BBT-877, a novel inhibitor of ATX, on a mouse model of type 1 diabetic nephropathy
Authors
Keywords
-
Journal
Aging-US
Volume 14, Issue 16, Pages 6467-6480
Publisher
Impact Journals, LLC
Online
2022-08-26
DOI
10.18632/aging.204249
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phenotypic diversity and metabolic specialization of renal endothelial cells
- (2021) Sébastien J. Dumas et al. Nature Reviews Nephrology
- Transforming growth factor–β in tissue fibrosis
- (2020) Nikolaos G. Frangogiannis JOURNAL OF EXPERIMENTAL MEDICINE
- Increased Levels of Renal Lysophosphatidic Acid in Rodent Models with Renal Disease
- (2020) Takashi Hirata et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Lysophosphatidic acid receptor 1 inhibitor, AM095, attenuates diabetic nephropathy in mice by downregulation of TLR4/NF-κB signaling and NADPH oxidase
- (2019) Jong Han Lee et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Lysophosphatidic Acid Signaling in Diabetic Nephropathy
- (2019) Jong Lee et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Idiopathic Pulmonary Fibrosis: Cell Death and Inflammation Revisited
- (2018) Claude Jourdan Le Saux et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Pharmacologic targeting of the ATX/LPA axis attenuates bleomycin-induced pulmonary fibrosis
- (2018) Ioanna Ninou et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Urinary lysophopholipids are increased in diabetic patients with nephropathy
- (2017) Jean-Sébastien Saulnier-Blache et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Lysophosphatidic Acid Receptor Antagonism Protects against Diabetic Nephropathy in a Type 2 Diabetic Model
- (2017) Ming-Zhi Zhang et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Blocking lysophosphatidic acid receptor 1 signaling inhibits diabetic nephropathy in db/db mice
- (2017) Hui Ying Li et al. KIDNEY INTERNATIONAL
- Role of lysophosphatidic acid and its receptors in the kidney
- (2017) Frank Park et al. PHYSIOLOGICAL GENOMICS
- Serum Autotaxin Levels Are Associated with Proteinuria and Kidney Lesions in Japanese Type 2 Diabetic Patients with Biopsy-proven Diabetic Nephropathy
- (2016) Miho Shimizu et al. INTERNAL MEDICINE
- Lysophosphatidic acid signalling in development
- (2015) X. Sheng et al. DEVELOPMENT
- ENPP2 Contributes to Adipose Tissue Expansion and Insulin Resistance in Diet-Induced Obesity
- (2014) S. Nishimura et al. DIABETES
- Diabetic nephropathy induces alterations in the glomerular and tubule lipid profiles
- (2014) Kerri J. Grove et al. JOURNAL OF LIPID RESEARCH
- Lysophosphatidic acid impairs glucose homeostasis and inhibits insulin secretion in high-fat diet obese mice
- (2013) C. Rancoule et al. DIABETOLOGIA
- Cytokine mediated tissue fibrosis
- (2012) Lee A. Borthwick et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Inflammation, wound repair, and fibrosis: reassessing the spectrum of tissue injury and resolution
- (2012) Eric S White et al. JOURNAL OF PATHOLOGY
- Mechanistic connection between inflammation and fibrosis
- (2010) Soo Bong Lee et al. KIDNEY INTERNATIONAL
- The Role of Toll-Like Receptor 2 in Inflammation and Fibrosis during Progressive Renal Injury
- (2009) Jaklien C. Leemans et al. PLoS One
- Lysophosphatidic acid and renal fibrosis
- (2008) J PRADERE BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started